|
TIA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.43660000351665E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.75639999953215E-07 |
| Normal-vs-Stage2 |
8.137300E-03 |
| Normal-vs-Stage3 |
7.988400E-02 |
| Normal-vs-Stage4 |
3.612000E-01 |
| Stage1-vs-Stage2 |
6.292600E-01 |
| Stage1-vs-Stage3 |
1.393920E-02 |
| Stage1-vs-Stage4 |
2.629600E-01 |
| Stage2-vs-Stage3 |
8.304200E-02 |
| Stage2-vs-Stage4 |
2.352600E-01 |
| Stage3-vs-Stage4 |
9.619200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.61769999804807E-08 |
| Normal-vs-AfricanAmerican |
1.993410E-04 |
| Normal-vs-Asian |
1.095180E-01 |
| Caucasian-vs-AfricanAmerican |
6.890600E-01 |
| Caucasian-vs-Asian |
5.026000E-01 |
| AfricanAmerican-vs-Asian |
5.919000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.29999999945952E-08 |
| Normal-vs-Female |
4.24479999999727E-05 |
| Male-vs-Female |
6.091800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.737500E-03 |
| Normal-vs-Extreme_Weight |
8.33420000000418E-05 |
| Normal-vs-Obese |
4.39589999999823E-05 |
| Normal-vs-Extreme_Obese |
3.755200E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.710200E-01 |
| Normal_Weight-vs-Obese |
5.604600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.890800E-01 |
| Extreme_Weight-vs-Obese |
5.990000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.412400E-01 |
| Obese-vs-Extreme_Obese |
9.399400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.575500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.13040000085485E-08 |
| Normal-vs-Age(61-80Yrs) |
4.28220000003865E-06 |
| Normal-vs-Age(81-100Yrs) |
3.733400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.296600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.949000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.527500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.239770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.484200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.369760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.16849863118773E-11 |
| Normal-VS-Type2 PRCC |
7.259800E-01 |
| Normal-VS-KIRP CIMP |
6.671600E-01 |
| Normal-VS-Unclassified PRCC |
2.220500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.07611705604904E-14 |
| Type1 PRCC-VS-KIRP CIMP |
2.387000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.666200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.606000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.990300E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
4.070200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.083500E-03 |
| Normal-vs-N1 |
4.453700E-02 |
| Normal-vs-N2 |
8.739000E-01 |
| N0-vs-N1 |
6.601200E-01 |
| N0-vs-N2 |
2.440200E-01 |
| N1-vs-N2 |
3.109000E-01 |
|
|
